BASE PERIOD (YEAR 1): SUPPORT SERVICES RELATED TO CANCER REGISTRY CLAIMS ELECTRONIC DATA CAPTURE SOFTWARE SUPPORT AND INSTALLATIONS

法律要求所有50个州的医疗保健提供者向该州的癌症登记处报告新的癌症病例。美国国家癌症研究所（NCI）的监测、流行病学和最终结果（SEER）项目收集了SEER覆盖区域内每一位癌症患者的数据。这些数据包括人口统计、癌症描述、有限的初始治疗信息和患者随访，包括死亡患者的死因。过去，登记数据的主要来源是医院。随着癌症治疗和提供系统的日益复杂，越来越多的患者只能在医生办公室接受治疗。因此，为了让SEER继续获取所有癌症病例及其治疗信息，SEER有兴趣获取其他数据来源，例如来自肿瘤学实践的索赔数据。肿瘤实践声明已被证明是详细的全身治疗的丰富信息来源，包括药物，剂量给药日期等。

Healthcare providers in all 50 states are required by law to report new cases of cancer to their state’s cancer registries. The National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) Program, collects data on each and every cancer patient in SEER covered areas. This data includes demographics, a description of their cancer, limited initial treatment information, and patient follow-up including cause of death for deceased patients. In the past the main source of registry data came from Hospitals. With the increasing complexity of cancer care and delivery systems, patients are being increasingly treated exclusively at physicians’ offices. Thus, for SEER to continue capturing all cancer cases and their treatment information SEER is interested in obtaining other sources of data such as claims data from oncology practices. Oncology practice claims has proven to be a rich source of information on detailed systemic therapy, including agents, doses administration dates etc. Beginning in 2015, the NCI SEER Program began supporting the procurement of oncology practice claims data for six (6) SEER central cancer registries from Unlimited Technology Systems, LLC. Unlimited Technology Systems, LLC provides healthcare information systems to a national community of oncology practices. In addition to obtaining cancer treatment information for cases recently diagnosed, SEER is interested in evaluating the long history of claims to assess longitudinal treatment as well as progression and/or cancer recurrence. To do this, it is crucial to have a very long series of longitudinal claims on the same cancer patient. The SEER Program has already obtained claims for a substantial number of SEER cancer patients for the years 2013-2017 for Georgia, Kentucky, Louisiana, New Mexico and Utah, and year 2018 for Iowa from oncology practices and oncologists, referenced here as providers. The current Unlimited Technology Systems, LLC providers have already provided consent to Unlimited Technology Systems, LLC to send claims to the respective central cancer registries to fulfil their obligation in reporting cancer cases. These claims are currently being used by SEER registries to ascertain new cancer cases more rapidly as the claims are received weekly, to capture systemic therapy and to ascertain follow-up information in terms of vital status of cancer patients. The SEER Program is interested in continuing to support the transmission of claims data for current providers, as well as to support the expansion of this capability, for additional providers within the SEER regions, or new states/areas covered by cancer registration that the Program identifies as important to obtain claims data information. This project is critical in order for SEER to continue being relevant and advance cancer surveillance and research.